Urani Alexandre, Gass Peter
Central Institute of Mental Health (CIMA), University of Heidelberg, D-68159 Mannheim, Germany.
Ann N Y Acad Sci. 2003 Dec;1007:379-93. doi: 10.1196/annals.1286.037.
Dysregulations and dysfunctions of corticosteroids and their receptors have been implicated in the pathogenesis of stress-related disorders, in particular in depression. It is currently under debate, however, whether corticosteroid imbalances are a cause or rather a consequence of affective disorders. Corticosteroids exert their effects mainly by two receptors: glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs). We present here analyses made on several strains of mice with targeted mutations of corticosteroid receptors. The results help to understand how corticosteroid receptors regulate the hypothalamic-pituitary-adrenal (HPA) system. Furthermore, first behavioral analyses have indicated that corticosteroid receptor mutant mice show alterations in their emotional behavior. Certain mouse strains with specific alterations of GR or MR expression may represent genetic models of depression or at least have a predisposition to develop a depressive or a depression-resistant state upon exposure to stress. The corticosteroid receptor-regulated target genes to be identified in these models may code for proteins that could represent new drug-targets for the treatment of affective disorders.
皮质类固醇及其受体的失调和功能障碍与应激相关疾病的发病机制有关,尤其是抑郁症。然而,目前仍在争论皮质类固醇失衡是情感障碍的原因还是结果。皮质类固醇主要通过两种受体发挥作用:糖皮质激素受体(GRs)和盐皮质激素受体(MRs)。我们在此展示了对几种具有皮质类固醇受体靶向突变的小鼠品系的分析。这些结果有助于了解皮质类固醇受体如何调节下丘脑-垂体-肾上腺(HPA)系统。此外,初步的行为分析表明,皮质类固醇受体突变小鼠的情绪行为发生了改变。某些GR或MR表达有特定改变的小鼠品系可能代表抑郁症的遗传模型,或者至少在受到压力时易发展为抑郁或抗抑郁状态。在这些模型中有待鉴定的皮质类固醇受体调节的靶基因可能编码可作为情感障碍治疗新药靶点的蛋白质。